Here are relevant reports on : cancer-diagnostics-market
-
Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region - Global Forecast to 2030
The global prefilled syringe market, valued at US$6.40 billion in 2023, stood at US$7.10 billion in 2024 and is projected to advance at a resilient CAGR of 10.8% from 2024 to 2030, culminating in a forecasted valuation of US$13.14 billion by the end of the period. The market for prefilled syringes is expanding significantly as a result of rising chronic illness rates that necessitate frequent treatment, and growing demand for effective and practical drug delivery methods.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Cancer Vaccines Market by Type (Preventive, Therapeutic (Neoantigen)), Technology (Cell-based Vaccine, Recombinant), Indication (Cervical, Prostate), ROA (Intramuscular, Intravenous), End User (Hospitals, Speciality Clinics) - Global Forecast to 2032
The global cancer vaccines market, valued at US$9.70 billion in 2023, stood at US$9.84 billion in 2024 and is projected to advance at a resilient CAGR of 5.4% from 2024 to 2032, culminating in a forecasted valuation of US$15.00 billion by the end of the period. The cancer vaccines market is growing rapidly, fueled by rising prevalence of cancer, technological advancements in immunotherapy, and increasing adoption of preventive healthcare across the globe.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Plant-based Beverages Market by Source (Almond, Soy, Coconut, and Rice), Type (Milk and Other Drinks), Function (Cardiovascular health, Cancer prevention, Lactose intolerance, and Bone health) and Region - Global Forecast to 2023
The global plant-based beverages market is estimated to be valued at USD 11.16 billion in 2018 and is projected to reach USD 19.67 billion by 2023, at a CAGR of 12.0% during the forecast period. Plant-based beverages provide consumers with options that are low in cholesterol and calories. The growth of the market is attributed to the shift in preference towards vegan diets among consumers at a global level. Apart from this, major food companies such as Danone (US) have been showing interest in plant-based beverages; this is expected to give the market a boost. This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It includes the profiles of leading companies such as The WhiteWave Foods Company (US), Blue Diamond Growers (US), Pacific Foods (US), Hain Celestial (US), SunOpta (Canada), Want Want China Holdings Limited (China), Kikkoman(Japan), Califia Farms (US), The Coca-Cola Company (US), Ripple Foods (US), WildWood Organic (US), and Pureharvest (Australia).
- Published: October 2018
- Price: $ 4950
- TOC Available:
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030
The global injectable drug delivery market, valued at US$633.77 billion in 2024, stood at US$690.23 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of US$1,034.78 billion by the end of the period. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics.
- Published: May 2025
- Price: $ 8150
- TOC Available:
-
Lung Cancer Surgery Market by Instrument ((Clamps, Foreceps, Trocars, Retractors, Scissors), Monitoring & Endoscopic Devices), Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), MIS), Volume Data & Region - Global Forecast to 2026
The global lung cancer surgery market growth is primed to transition from $5.4 billion in 2020 to $6.7 billion by 2026, showcasing a strong CAGR of 3.8%. Market growth is largely driven by factors such as the technological advancements in lung cancer treatment, the increasing incidence and prevalence of lung cancer, the growing trend of smoking tobacco, the rising geriatric population, the increasing emphasis on early diagnosis and treatment of cancers, and the availability of reimbursement.
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious, Neurological), Application (Diagnostic, Research) - Global Forecast to 2030
The global biomarkers market, valued at US$58.07 billion in 2024, stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$104.15 billion by the end of the period. This growth is supported by the growing use of biomarkers in drug development and the increasing role of companion diagnostics in advancing precision medicine.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Dermatology Devices Market Size, Growth by Type (Diagnostic Devices (Dermatoscopes, Imaging Devices), Treatment Devices (Laser, Cryotherapy, Liposuction)), Application (Skin Cancer, Acne, Psoriasis, Skin Rejuvenation, Tattoo Removal) & Region - Global Forecast to 2027
The global dermatology devices market in terms of revenue was estimated to be worth $6.2 billion in 2022 and is poised to reach $11.3 billion by 2027, growing at a CAGR of 12.7% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Ablation Technologies Market (2011-2016) - (Cancer/tumor, Cardiac, Gynecology, Orthopedics, Radiofrequency, Cryoablation, Microwave, Hydrothermal, Radiation and Laser/ Light) - Global Trends & Competitive Analysis
The global ablation technologies market consists of thermal and non- thermal ablation technologies. Under thermal ablation technologies, radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies are included, whereas non-thermal ablation technologies include cryoablation and hydromechanical. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Home Healthcare Market by Product (Therapeutic, Testing, Screening, Monitoring, Mobility Care), Service (Nursing, Infusion Therapy, Rehabilitation, Palliative Care), Indication (Cancer, Diabetes, CVD, Respiratory, Wound Care) - Global Forecast to 2030
The global home healthcare market, valued at US$285.3 billion in 2024, stood at US$309.9 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$473.8 billion by the end of the period. This growth is driven by the rising elderly population, which is more prone to chronic conditions such as hypertension, diabetes, and cardiovascular diseases, increasing the need for ongoing care at home.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Refurbished Medical Equipment Market by Product (Imaging (MRI, CT), Patient Monitor, Defibrillator, Dialysis, Lithotripsy, Ventilator, Incubators, Operating & Surgical Equipment), Application (CVS, Cancer, Ob/Gyn), Enduser - Global Forecast to 2029
The global refurbished medical equipment market, valued at US$15.97 million in 2023, stood at US$16.93 million in 2024 and is projected to advance at a resilient CAGR of 7.6% from 2024 to 2029, culminating in a forecasted valuation of US$24.41 million by the end of the period. The market growth for Refurbished medical equipment is influenced by increasing healthcare expenditures, growing need for affordable healthcare equipment, availability of advanced used equipment, and increasing cost of new equipment while maintaining quality.
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
